» Articles » PMID: 24573250

Development of Lipid-shell and Polymer Core Nanoparticles with Water-soluble Salidroside for Anti-cancer Therapy

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2014 Feb 28
PMID 24573250
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Salidroside (Sal) is a potent antitumor drug with high water-solubility. The clinic application of Sal in cancer therapy has been significantly restricted by poor oral absorption and low tumor cell uptake. To solve this problem, lipid-shell and polymer-core nanoparticles (Sal-LPNPs) loaded with Sal were developed by a double emulsification method. The processing parameters including the polymer types, organic phase, PVA types and amount were systemically investigated. The obtained optimal Sal-LPNPs, composed of PLGA-PEG-PLGA triblock copolymers and lipids, had high entrapment efficiency (65%), submicron size (150 nm) and negatively charged surface (-23 mV). DSC analysis demonstrated the successful encapsulation of Sal into LPNPs. The core-shell structure of Sal-LPNPs was verified by TEM. Sal released slowly from the LPNPs without apparent burst release. MTT assay revealed that 4T1 and PANC-1 cancer cell lines were sensitive to Sal treatment. Sal-LPNPs had significantly higher antitumor activities than free Sal in 4T1 and PANC-1 cells. The data indicate that LPNPs are a promising Sal vehicle for anti-cancer therapy and worthy of further investigation.

Citing Articles

Preparation of a minocycline polymer micelle thermosensitive gel and its application in spinal cord injury.

Gu J, Cai X, Raza F, Zafar H, Chu B, Yuan H Nanoscale Adv. 2024; .

PMID: 39355839 PMC: 11440374. DOI: 10.1039/d4na00625a.


Fabrication and characterization of salidroside W/O/W emulsion with sodium alginate.

Zhang Q, Wang Y, Li L, Song H, Wu H, Zhu B Food Chem X. 2024; 22:101260.

PMID: 38450386 PMC: 10915508. DOI: 10.1016/j.fochx.2024.101260.


Cytotoxicity Activity, Metabolite Profiling, and Isolation Compound from Crude Hexane Extract of Cleome rutidospermae.

Yasir B, Rahim A, Lallo S, Saito Y, Goto K, Rohman A Asian Pac J Cancer Prev. 2023; 24(10):3345-3352.

PMID: 37898837 PMC: 10770682. DOI: 10.31557/APJCP.2023.24.10.3345.


Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics.

Gajbhiye K, Salve R, Narwade M, Sheikh A, Kesharwani P, Gajbhiye V Mol Cancer. 2023; 22(1):160.

PMID: 37784179 PMC: 10546754. DOI: 10.1186/s12943-023-01849-0.


Chrysin and chrysin-loaded nanocarriers induced immunogenic cell death on B16 melanoma cells.

Oliyapour Y, Dabiri S, Molavi O, Hejazi M, Davaran S, Jafari S Med Oncol. 2023; 40(10):278.

PMID: 37624439 DOI: 10.1007/s12032-023-02145-z.


References
1.
Hadinoto K, Sundaresan A, Cheow W . Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review. Eur J Pharm Biopharm. 2013; 85(3 Pt A):427-43. DOI: 10.1016/j.ejpb.2013.07.002. View

2.
Li J, He Z, Yu S, Li S, Ma Q, Yu Y . Micelles based on methoxy poly(ethylene glycol)-cholesterol conjugate for controlled and targeted drug delivery of a poorly water soluble drug. J Biomed Nanotechnol. 2012; 8(5):809-17. DOI: 10.1166/jbn.2012.1433. View

3.
Kumar M, Bakowsky U, Lehr C . Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials. 2004; 25(10):1771-7. DOI: 10.1016/j.biomaterials.2003.08.069. View

4.
Mussi S, Silva R, de Oliveira M, Lucci C, Azevedo R, Ferreira L . New approach to improve encapsulation and antitumor activity of doxorubicin loaded in solid lipid nanoparticles. Eur J Pharm Sci. 2012; 48(1-2):282-90. DOI: 10.1016/j.ejps.2012.10.025. View

5.
Zhu Y, Shi Y, Wu D, Ji Y, Wang X, Chen H . Salidroside protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via PI3K-Akt dependent pathway. DNA Cell Biol. 2011; 30(10):809-19. DOI: 10.1089/dna.2010.1183. View